CDNA

Caredx, Inc.

A precision medicine company focused on keeping transplanted organs healthy. CareDx makes non-invasive blood tests — AlloMap Heart and the AlloSure Kidney, Heart, and Lung panels — that monitor transplant recipients for early signs of rejection without a biopsy, along with HLA typing kits and AlloSeq gene-sequencing tools used to match donors and recipients. Its Ottr and MedActionPlan software help transplant teams track and manage patient care between visits.

Recent Activity

Show $

2026Q2

1 buy3 sells

ARK Genomic Revolution ETFTRIM

-117.0K shares(-5.5%)

ARK Genomic Revolution ETFTRIM

-117.0K shares(-5.5%)

ARK InvestTRIM

-274.0K shares(-12.3%)

ARK InvestTRIM

-274.0K shares(-12.3%)

ArrowMark PartnersTRIM

-148.1K shares(-30.4%)

ArrowMark PartnersTRIM

-148.1K shares(-30.4%)

First Eagle Investment ManagementADD

+23.1K shares(+4.0%)

First Eagle Investment ManagementADD

+23.1K shares(+4.0%)

2026Q1

2 buys2 sells

ARK Genomic Revolution ETFTRIM

-12.7K shares(-0.6%)

ARK Genomic Revolution ETFTRIM

-12.7K shares(-0.6%)

ARK InvestADD

+91.2K shares(+4.3%)

ARK InvestADD

+91.2K shares(+4.3%)

ArrowMark PartnersTRIM

-271.7K shares(-35.8%)

ArrowMark PartnersTRIM

-271.7K shares(-35.8%)

First Eagle Investment ManagementADD

+28.6K shares(+5.2%)

First Eagle Investment ManagementADD

+28.6K shares(+5.2%)

Loading more activity...